Table 1 Baseline demographic and clinical characteristics
Characteristics | Value |
|---|---|
Age(years) | 72.2(11.6) |
Male/Female | 23/25 |
Primary renal disease | |
Vascular nephropathy | 23(49%) |
Glomerulonephritis | 2(4%) |
Interstitial nephropathy/polycystic kidney disease | 3(6%) |
Diabetes | 12(26%) |
Unknown | 7(15%) |
Chronic kidney disease stage | |
Stage 3 | 13(28% |
Stage 4 | 27(57%) |
Stage 5 | 7(15%) |
Use of erythropoiesis stimulating agents | 23(49%) |
Use of phosphate binders | 4(8.5%) |
Use of active vitamin D | 18(38%) |
Use of cinacalcet hydrochloride | 1(2%) |
Serum creatine, mg/dL | 2.56(0.95) |
eGFR, ml/min per 1.73 m2 | 26.1(10.4) |
Haemoglobin, g/dL | 10(0.7) |
Ferritin, ng/mL | 67.8(61.7) |
Transferrin saturation, % | 14.6(6.4) |
Calcium, mg/dL | 9.3(0.4) |
Phosphate, mg/dL | 4.2(0.8) |
PTH, pg/mL | 138.1(2.5-600) |
25-hydroxyvitamin D, ng/ml | 12.8(6.6) |
1,25 dihydroxyvitamin D, pg/mL | 9.7(4.4) |
Fibroblast growth factor 23, RU/mL | 442(44.9-4079.2) |